Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Gastrointestinal Medicine
Volume 2017, Article ID 8765264, 6 pages
https://doi.org/10.1155/2017/8765264
Case Report

Asymptomatic Pancreatic Metastasis from Renal Cell Carcinoma Diagnosed 21 Years after Nephrectomy

1Department of Gastroenterology, Komatsu Municipal Hospital, Ishikawa, Japan
2Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan
3Department of Pathology, Komatsu Municipal Hospital, Ishikawa, Japan

Correspondence should be addressed to Naoki Takahashi; moc.liamg@32600891ikoan

Received 15 June 2017; Revised 29 July 2017; Accepted 2 August 2017; Published 30 August 2017

Academic Editor: Hideto Kawaratani

Copyright © 2017 Megumi Zianne et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2015,” CA: Cancer Journal for Clinicians, vol. 65, no. 1, pp. 5–29, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. D. J. Grignon and M. Che, “Clear cell renal cell carcinoma,” Clinics in Laboratory Medicine, vol. 25, no. 2, pp. 305–316, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Bianchi, M. Sun, C. Jeldres et al., “Distribution of metastatic sites in renal cell carcinoma: a population-based analysis,” Annals of Oncology, vol. 23, no. 4, pp. 973–980, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. K. A. Klein, D. H. Stephens, and T. J. Welch, “CT characteristics of metastatic disease of the pancreas,” Radiographics, vol. 18, no. 2, pp. 369–378, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Ghavamian, K. A. Klein, D. H. Stephens et al., “Renal cell carcinoma metastatic to the pancreas: Clinical and radiological features,” Mayo Clinic Proceedings, vol. 75, no. 6, pp. 581–585, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Palmowski, N. Hacke, S. Satzl et al., “Metastasis to the pancreas: Characterization by morphology and contrast enhancement features on CT and MRI,” Pancreatology, vol. 8, no. 2, pp. 199–203, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. Eloubeidi, D. Jhala, D. C. Chhieng, N. Jhala, I. Eltoum, and C. M. Wilcox, “Multiple late asymptomatic pancreatic metastases from renal cell carcinoma: diagnosis by endoscopic ultrasound-guided fine needle aspiration biopsy with immunocytochemical correlation,” Digestive Diseases and Sciences, vol. 47, no. 8, pp. 1839–1842, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Béchade, L. Palazzo, M. Fabre, and J.-P. Algayres, “EUS-guided FNA of pancreatic metastasis from renal cell carcinoma,” Gastrointestinal Endoscopy, vol. 58, no. 5, pp. 784–788, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Kawakami, M. Kuwatani, H. Yamato et al., “Pancreatic metastasis from renal cell carcinoma with intraportal tumor thrombus,” Internal Medicine, vol. 47, no. 22, pp. 1967–1970, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. I. I. El Hajj, J. K. Leblanc, S. Sherman et al., “Endoscopic ultrasound-guided biopsy of pancreatic metastases: a large single-center experience,” Pancreas, vol. 42, no. 3, pp. 524–530, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. S. M. Gilani, R. Tashjian, R. Danforth, and L. Fathallah, “Metastatic renal cell carcinoma to the pancreas: diagnostic significance of fine-needle aspiration cytology,” Acta Cytologica, vol. 57, no. 4, pp. 418–422, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Waters, Q. Si, N. Caraway, D. Mody, G. Staerkel, and N. Sneige, “Secondary tumors of the pancreas diagnosed by endoscopic ultrasound-guided fine-needle aspiration: a 10-year experience,” Diagnostic Cytopathology, vol. 42, no. 9, pp. 738–743, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. H. H. Okasha, E. H. Al-Gemeie, and R. E. Mahdy, “Solitary pancreatic metastasis from renal cell carcinoma 6 years after nephrectomy,” Endoscopic Ultrasound, vol. 2, no. 4, pp. 222–224, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. A. L. Smith, S. I. Odronic, B. S. Springer, and J. P. Reynolds, “Solid tumor metastases to the pancreas diagnosed by FNA: a single-institution experience and review of the literature,” Cancer Cytopathology, vol. 123, no. 6, pp. 347–355, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Alomari, B. Ustun, H. Aslanian, X. Ge, D. Chhieng, and G. Cai, “Endoscopic ultrasound-guided fine-needle aspiration diagnosis of secondary tumors involving the pancreas: An institution’s experience,” CytoJournal, vol. 13, no. 1, article A1, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Pannala, K. M. Hallberg-Wallace, and A. L. Smith, “Endoscopic ultrasound-guided fine needle aspiration cytology of metastatic renal cell carcinoma to the pancreas: a multi-center experience,” CytoJournal, vol. 13, no. 1, pp. 13–24, 2016. View at Publisher · View at Google Scholar
  17. N. K. Janzen, H. L. Kim, R. A. Figlin, and A. S. Belldegrun, “Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease,” The Urologic Clinics of North America, vol. 30, no. 4, pp. 843–852, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Sperti, G. Pozza, A. R. Brazzale et al., “Metastatic tumors to the pancreas: A systematic review and meta-analysis,” Minerva Chirurgica, vol. 71, no. 5, pp. 337–344, 2016. View at Google Scholar · View at Scopus
  19. J.-P. Faure, J.-J. Tuech, J.-P. Richer, P. Pessaux, J.-P. Arnaud, and M. Carretier, “Pancreatic metastasis of renal cell carcinoma: Presentation, treatment and survival,” Journal of Urology, vol. 165, no. 1, pp. 20–22, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Ravaud, R. J. Motzer, H. S. Pandha et al., “Adjuvant sunitinib in high-risk renal-cell carcinoma after nephrectomy,” New England Journal of Medicine, vol. 375, no. 23, pp. 2246–2254, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. N. B. Haas, J. Manola, R. G. Uzzo et al., “Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): A double-blind, placebo-controlled, randomised, phase 3 trial,” The Lancet, vol. 387, no. 10032, pp. 2008–2016, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. P. J. Tanis, N. A. van der Gaag, O. R. C. Busch, T. M. van Gulik, and D. J. Gouma, “Systematic review of pancreatic surgery for metastatic renal cell carcinoma,” British Journal of Surgery, vol. 96, no. 6, pp. 579–592, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Zerbi, E. Ortolano, G. Balzano, A. Borri, A. A. Beneduce, and V. Di Carlo, “Pancreatic metastasis from renal cell carcinoma: Which patients benefit from surgical resection?” Annals of Surgical Oncology, vol. 15, no. 4, pp. 1161–1168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. R. J. Motzer, T. E. Hutson, P. Tomczak et al., “Sunitinib versus interferon alfa in metastatic renal-cell carcinoma,” The New England Journal of Medicine, vol. 356, no. 2, pp. 115–124, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Escudier, T. Eisen, W. M. Stadler et al., “Sorafenib in advanced clear-cell renal-cell carcinoma,” The New England Journal of Medicine, vol. 356, no. 2, pp. 125–134, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. R. J. Motzer, B. Escudier, S. Oudard et al., “Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial,” The Lancet, vol. 372, no. 9637, pp. 449–456, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. B. I. Rini, B. Escudier, P. Tomczak et al., “Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial,” The Lancet, vol. 378, no. 9807, pp. 1931–1939, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. R. J. Motzer, T. E. Hutson, D. Cella et al., “Pazopanib versus sunitinib in metastatic renal-cell carcinoma,” The New England Journal of Medicine, vol. 369, no. 8, pp. 722–731, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. R. J. Motzer, B. Escudier, and D. F. McDermott, “Nivolumab versus everolimus in advanced renal-cell carcinoma,” New England Journal of Medicine, vol. 373, no. 19, pp. 1803–1813, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. N. G. Ordóñez, “Value of PAX8 immunostaining in tumor diagnosis: a review and update,” Advances in Anatomic Pathology, vol. 19, no. 3, pp. 140–151, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. A. K. Avery, J. Beckstead, A. A. Renshaw, and C. L. Corless, “Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms,” The American Journal of Surgical Pathology, vol. 24, no. 2, pp. 203–210, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. P. H. Tan, L. Cheng, and N. Rioux-Leclercq, “Renal tumors: diagnostic and prognostic biomarkers,” The American Journal of Surgical Pathology, vol. 37, no. 10, pp. 1518–1531, 2013. View at Publisher · View at Google Scholar